Asset Details
Do you wish to reserve the book?
Initial Experience of Multipurpose Mechanical Aspiration System for Acute High‐Risk Pulmonary Embolism: A Prospective Multi‐Center Case Series
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Initial Experience of Multipurpose Mechanical Aspiration System for Acute High‐Risk Pulmonary Embolism: A Prospective Multi‐Center Case Series
Do you wish to request the book?
Initial Experience of Multipurpose Mechanical Aspiration System for Acute High‐Risk Pulmonary Embolism: A Prospective Multi‐Center Case Series
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Initial Experience of Multipurpose Mechanical Aspiration System for Acute High‐Risk Pulmonary Embolism: A Prospective Multi‐Center Case Series
2025
Overview
High‐risk acute pulmonary embolism (PE) is associated with significant in‐hospital mortality. Large‐Bore Mechanical Thrombectomy (LBMT) is a treatment option for acute PE, but data on its efficacy in high‐risk PE was limited. This prospective case series reported the outcomes of 14 patients with high‐risk PE treated using a novel multipurpose mechanical aspiration system (MMAS). Most patients were in hemodynamic decompensation, requiring inotropic or mechanical circulatory support. The mean procedural time was 73.5 ± 39.2 min. Complete procedural success was achieved in 78.6% of the cases, while two patients required bailout therapies. The mean pulmonary arterial pressure decreased by 27.2%, and the right‐ventricle/left‐ventricle ratio normalized in 85.7% of patients. The primary endpoint—in‐hospital mortality—was 0%, while the major bleeding rate was 27.2%. These findings suggest that MMAS is a safe and effective intervention for acute high‐risk PE.
Publisher
John Wiley & Sons, Inc,Wiley
Subject
